Skip to Content

ProAir HFA Approval History

  • FDA approved: Yes (First approved October 29th, 2004)
  • Brand name: ProAir HFA
  • Generic name: albuterol sulfate
  • Dosage form: Inhalation Aerosol
  • Company: Teva Pharmaceutical Industries Ltd.
  • Treatment for: Asthma

ProAir HFA (albuterol sulfate) inhalation aerosol is a beta2-adrenergic agonist indicated for treatment or prevention of bronchospasm.

Development History and FDA Approval Process for ProAir HFA

DateArticle
Sep 24, 2008Approval Teva's ProAir HFA, the Market Leading Albuterol Inhaler, Receives New Pediatric Indication

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide